ROIVANT SCIENCES LTD. Earnings Per Share, Basic and Diluted
ROIVANT SCIENCES LTD. (ROIV) reported Earnings Per Share, Basic and Diluted of -$1.26 per share for the 12-month period ending 2022-03-31, per its 10-K filed 2022-06-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-06-28
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.41.
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.32.
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.37.
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.41.
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for fiscal 2022 was -$1.26.
- ROIVANT SCIENCES LTD. earnings per share, basic and diluted for fiscal 2021 was -$1.28.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.26 10-K · filed 2022-06-28 | |||
| 2021-12-31 | -$0.41 10-Q · filed 2022-02-14 | -$0.87 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | -$0.32 10-Q · filed 2021-11-15 | -$0.45 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$0.37 10-Q · filed 2021-09-21 | |||
| 2021-03-31 | -$1.28 10-K · filed 2022-06-28 | |||
| 2020-12-31 | -$0.41 10-Q · filed 2022-02-14 | -$0.48 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-15 | -$0.06 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$0.02 10-Q · filed 2021-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |